/PRNewswire/ DelveInsight s Anti-Radiation Drugs Market Insights report provides the current and forecast market analysis, individual leading anti-radiation.
The rise in demand for anti-radiation drugs is mainly driven by several factors. These include the growing occurrence of side effects linked to cancer screening methods, heightened risks of
On May 15, 2024, Paul Diaz, President and Chief Executive Officer of Myriad Genetics Inc (NASDAQ:MYGN), executed a significant transaction by selling 227,844 shares of the company.
Cancer Diagnostics Market size is set to grow by USD 12. 63 Bn from 2023-2027, high prevalence of cancer to boost the market growth, Technavio prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.